![]() |
市場調査レポート
商品コード
1451543
整形外科インプラント市場レポート:製品タイプ、生体材料、エンドユーザー、地域別、2024-2032Orthopedic Implants Market Report by Product, Type, Biomaterial, End User, and Region 2024-2032 |
||||||
カスタマイズ可能
|
整形外科インプラント市場レポート:製品タイプ、生体材料、エンドユーザー、地域別、2024-2032 |
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2~3営業日
|
整形外科インプラントの世界市場規模は2023年に535億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに794億米ドルに達し、2024~2032年の成長率(CAGR)は4.4%になると予測しています。高齢化人口の増加、整形外科インプラントの材料・設計・手術手技の大幅な進歩、座りがちなライフスタイルと肥満、ヘルスケアインフラと整形外科医療へのアクセスの増加が、市場を推進する主な要因の一部です。
整形外科インプラントは、筋骨格系の状態や損傷に対処するために設計された特殊な医療機器です。これらのインプラントは、生体適合性、耐久性、人体との適合性などの主要な特性を示しています。インプラントは通常、チタン、ステンレス鋼、医療グレードのポリマーなどの素材から構成され、体内での長期的な安定性を保証します。整形外科インプラントには、人工股関節や人工膝関節のような関節置換術、骨折固定用のプレート、スクリュー、ロッド、脊椎疾患に対応する脊椎インプラントなど、幅広いデザインがあります。インプラントの主な機能は、整形外科疾患、骨折、退行性関節疾患を患う人々の可動性を回復し、痛みを和らげ、全体的な生活の質を向上させることです。
整形外科インプラントのデザインや素材における医療効果や技術的進歩に対する意識の高まりが、整形外科インプラント市場の成長を後押ししています。同様に、高度なヘルスケアソリューションに対する需要の増加と整形外科疾患への対処という課題が、世界的に医療処置における整形外科インプラントの重要性を強調しています。整形外科インプラントは、筋骨格系の機能回復と痛みの緩和において極めて重要な役割を果たしており、効果的で生体力学的に健全なソリューションに対するニーズの高まりに対応しています。流通経路の拡大と品質の標準化への取り組みが、市場の成長をさらに後押ししています。さらに、整形外科の健康に対する理解の深まり、低侵襲でありながら効果的な治療法への嗜好、持続可能で生体適合性の高い素材への注目などの要因が、世界中の多様なヘルスケア分野にわたって整形外科インプラント市場の成長を促進しています。
高齢化人口の着実な拡大
高齢化は整形外科インプラント市場の主な促進要因です。世界の人口統計プロファイルが高齢者人口へとシフトするにつれ、変形性関節症や骨折などの筋骨格系の問題の有病率が増加しています。高齢者は、生活の質や可動性を維持するために整形外科的介入を必要とすることが多いです。股関節や膝関節のインプラントを含む人工関節置換術は、この層の間で高い需要があります。特に新興国では高齢化人口が増え続けているため、整形外科インプラントの持続的な市場が確保されています。メーカー各社は、このような患者層の拡大に対応するため、高度なインプラント技術に投資しており、市場成長の主要な促進要因となっています。
技術の進歩と革新
技術の進歩は、整形外科インプラント市場の推進に重要な役割を果たしています。これらの技術革新は、材料、インプラントの設計、および手術技術を包含しています。チタンやセラミックのような生体適合材料は、人体とシームレスに統合するインプラントの開発にますます使用されるようになっています。最先端の画像診断とナビゲーション・システムに助けられた低侵襲手術は、手術による外傷と回復時間を軽減します。3Dプリンティングはインプラントの製造に革命をもたらし、より良い結果をもたらす患者固有のインプラントを可能にしました。さらに、耐摩耗性ポリエチレンのような先端材料の使用により、人工関節の寿命が延びました。技術の進歩は、インプラントの性能を向上させるだけでなく、患者の満足度も高めるため、市場成長の大きな原動力となっています。
スポーツ傷害の増加
スポーツや身体活動への参加の急増により、スポーツ関連の怪我の発生率が高くなっています。整形外科インプラントは、靭帯断裂、骨折、関節の不安定性などの症状を治療するために頻繁に必要とされます。若いアスリートやフィットネス愛好家は、活動的なライフスタイルに戻るために整形外科的ソリューションを求めるようになっています。この動向はプロのアスリートに限らず、レクリエーション・スポーツやフィットネス愛好家にも及んでいます。その結果、前十字靭帯(ACL)再建装置や肩関節インプラントなどの整形外科インプラントの需要が増加しています。スポーツや野外活動に従事する人が増えるにつれ、効果的な整形外科的介入に対するニーズは増大の一途をたどっており、スポーツ関連の傷害は市場拡大の重要な要因となっています。
The global orthopedic implants market size reached US$ 53.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 79.4 Billion by 2032, exhibiting a growth rate (CAGR) of 4.4% during 2024-2032. The increasing aging population, extensive advancements in orthopedic implant materials, designs, and surgical techniques, sedentary lifestyles and obesity, and increase in healthcare infrastructure and access to orthopedic care are some of the major factors propelling the market.
Orthopedic implants are specialized medical devices designed to address musculoskeletal conditions and injuries. These implants exhibit key characteristics such as biocompatibility, durability, and compatibility with the human body. They are typically constructed from materials like titanium, stainless steel, or medical-grade polymers, ensuring long-term stability within the body. Orthopedic implants feature a wide range of designs, including joint replacements like hip and knee prostheses, plates, screws, and rods for fracture fixation, and spinal implants for addressing spinal disorders. Their primary function is to restore mobility, relieve pain, and improve the overall quality of life for individuals suffering from orthopedic conditions, fractures, or degenerative joint diseases.
The rising awareness of the medical benefits and technological advancements in orthopedic implant design and materials is propelling the orthopedic implants market growth. Similarly, the increasing demand for advanced healthcare solutions and the challenge of addressing orthopedic conditions are emphasizing the significance of orthopedic implants in medical procedures globally. Orthopedic implants play a pivotal role in restoring musculoskeletal function and alleviating pain, meeting the growing need for effective, biomechanically sound solutions. The expansion of distribution channels and efforts to standardize quality are further bolstering market growth. Additionally, factors such as the evolving understanding of orthopedic health, a preference for minimally invasive yet effective treatments, and a focus on sustainable, biocompatible materials are driving the orthopedic implant market's growth across diverse healthcare sectors worldwide.
Steadily Expanding Aging Population Base
The aging population is a primary driver of the orthopedic implants market. As the global demographic profile shifts towards an older population, there is an increased prevalence of musculoskeletal issues such as osteoarthritis and fractures. Elderly individuals often require orthopedic interventions to maintain their quality of life and mobility. Joint replacements, including hip and knee implants, are in high demand among this demographic. The continuous growth of the aging population, particularly in developed countries, ensures a sustained market for orthopedic implants. Manufacturers are investing in advanced implant technologies to cater to this expanding patient base, making it a key driver of market growth.
Technological Advancements and Innovations
Advancements in technology play a crucial role in propelling the orthopedic implants market. These innovations encompass materials, implant designs, and surgical techniques. Biocompatible materials like titanium and ceramics are increasingly used to develop implants that integrate seamlessly with the human body. Minimally invasive procedures, aided by cutting-edge imaging and navigation systems, reduce surgical trauma and recovery time. 3D printing has revolutionized implant manufacturing, enabling patient-specific implants for better outcomes. Moreover, the use of advanced materials like wear-resistant polyethylene extends the lifespan of joint replacements. Technological advancements not only improve implant performance but also enhance patient satisfaction, making it a significant driver of market growth.
Increasing Incidences of Sports Injuries
The surge in sports and physical activity participation has led to a higher incidence of sports-related injuries. Orthopedic implants are frequently required to treat conditions like torn ligaments, fractures, and joint instability. Young athletes and fitness enthusiasts are increasingly seeking orthopedic solutions to return to their active lifestyles. This trend is not limited to professional athletes but extends to recreational sports and fitness enthusiasts. Consequently, the demand for orthopedic implants, such as anterior cruciate ligament (ACL) reconstruction devices and shoulder implants, is on the rise. As more people engage in sports and outdoor activities, the need for effective orthopedic interventions continues to grow, making sports-related injuries a significant driver of market expansion.
IMARC Group provides an analysis of the key trends in each segment of the global orthopedic implants market research report, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, type, biomaterial, and end user.
Reconstructive Joint Replacements
Knee Replacement Implants
Hip Replacement Implants
Extremities
Spinal Implants
Spinal Fusion Implants
Vertebral Compression Fracture (VCF) Devices
Motion Preservation Devices/Non-Fusion Devices
Dental Implants
Root Form Dental Implants
Plate Form Dental Implants
Trauma
Orthobiologics
Demineralized Bone Matrix (DBM)
Allograft
Bone Morphogenetic Protein (BMP)
Viscosupplementation Products
Synthetic Bone Substitutes
Others
Others
Reconstructive joint replacements represents the largest market segment
The report has provided a detailed breakup and analysis of the market based on the product. This includes reconstructive joint replacements (knee replacement implants, hip replacement implants, and extremities), spinal implants (spinal fusion implants, vertebral compression fracture (VCF) devices, and motion preservation devices/non-fusion devices), dental implants (root form and plate form dental implants), trauma, orthobiologics (demineralized bone matrix (DBM), allograft, bone morphogenetic protein (BMP), viscosupplementation products, synthetic bone substitutes, and others), and others. According to the report, reconstructive joint replacements represented the largest segment.
The orthopedic implants market for reconstructive joint replacements is segmented into distinct categories based on the type of joint involved, material used, and fixation technique. Primarily, the product types encompass hip replacements, knee replacements, shoulder replacements, and smaller joints like ankle, wrist, and elbow replacements. Among these, hip and knee replacements represent the most significant segments due to the high incidence of osteoarthritis and degenerative joint diseases in these areas. Material-wise, the market is segmented into metal alloys (such as stainless steel and cobalt-chromium), ceramics, and polymers. Each material offers unique benefits and potential drawbacks, and choices often depend on patient-specific needs and clinical circumstances. Regarding fixation techniques, the market can be broken down into cemented, cementless, and hybrid methods. Cemented replacements have been the traditional choice, providing immediate fixation.
Knee
Hip
Wrist and Shoulder
Dental
Spine
Ankle
Others
Knee represents the largest market segment
The report has provided a detailed breakup and analysis of the market based on the type. This includes knee, hip, wrist and shoulder, dental, spine, ankle, and others. According to the report, knee represented the largest segment.
Knee implants represent a significant type segment within the global orthopedic implants market. Knee-related orthopedic issues, such as osteoarthritis, ligament injuries, and fractures, are widespread globally. As the aging population increases, the demand for knee implants is on the rise, making it a substantial segment in the orthopedic implants market. Moreover, knee implants, such as total knee replacements, have the potential to significantly improve the quality of life for patients suffering from debilitating knee conditions. They restore mobility, reduce pain, and enhance overall functionality. In addition to this, continuous innovations in knee implant materials, designs, and surgical techniques have led to improved implant longevity and patient outcomes. These advancements attract both patients and healthcare professionals, further driving market growth.
Metallic Biomaterials
Stainless Steel
Titanium alloy
Cobalt alloy
Others
Ceramic Biomaterials
Polymers Biomaterials
Others
Metallic biomaterials represents the largest market segment
The report has provided a detailed breakup and analysis of the market based on the biomaterial. This includes metallic biomaterials (stainless steel, titanium alloy, cobalt alloy, and others), ceramic biomaterials, polymers biomaterials, and others. According to the report, metallic biomaterials represented the largest segment.
The market for orthopedic implants utilizing metallic biomaterials is segmented based on several key variables, such as the type of joint being replaced, the specific metal alloy used, and the intended clinical application. Metallic biomaterials are commonly employed in major joint replacements, such as hips, knees, and shoulders, given their strength and durability. Within this category, the market sees further division based on the type of metal alloy, including stainless steel, titanium alloys, and cobalt-chromium alloys. Stainless steel is often used for its affordability, but it's generally less resistant to wear compared to other materials. Titanium alloys are lauded for their biocompatibility and lower density, which makes them suitable for patients with metal sensitivities. Cobalt-chromium alloys are chosen for their wear resistance and mechanical strength. Furthermore, the market can also be segmented based on the fixation method: cemented, cementless, or hybrid fixation. Metallic biomaterials are versatile and can be employed in all these fixation techniques, each catering to specific clinical needs and patient demographics.
Hospitals
Orthopedic Clinic
Ambulatory Surgical Centers
Others
The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, orthopedic clinic, ambulatory surgical centers, and others.
Hospitals indeed constitute a pivotal end user segment in the global orthopedic implants market. Hospitals serve as the primary institutions where orthopedic implant surgeries are performed. These institutions have the necessary infrastructure, specialized orthopedic surgeons, and support staff to conduct a wide range of orthopedic implant procedures. Moreover, hospitals are accessible to a broad spectrum of patients, including those with acute orthopedic injuries, chronic conditions, and elective procedures. This accessibility ensures a consistent flow of orthopedic implant surgeries. Hospitals are equipped to handle orthopedic emergencies, such as fractures and dislocations, which often require immediate surgical intervention. The availability of orthopedic implants in hospitals is crucial in these critical situations.
Orthopedic clinics are dedicated facilities focused exclusively on orthopedic care. They are staffed with specialized orthopedic surgeons and medical professionals who have in-depth expertise in treating musculoskeletal conditions. They are well-suited for outpatient procedures, including arthroscopic surgeries, minor joint injections, and other minimally invasive interventions. These procedures often involve the use of orthopedic implants. These clinics are designed for efficiency, allowing for streamlined patient care. This is particularly beneficial for patients seeking prompt evaluation, diagnosis, and treatment of orthopedic issues. Patients can often secure appointments at orthopedic clinics more quickly than at hospitals, leading to faster access to orthopedic care and potential implant procedures.
Ambulatory surgical centers (ASCs) are designed for efficiency and convenience as they offer same-day surgical procedures, including many orthopedic implant surgeries, allowing patients to return home on the same day as their procedure. This reduces hospital stays and associated costs. Orthopedic implant procedures performed in ASCs are often more cost-effective than in hospitals. This can be appealing to patients and healthcare systems aiming to control healthcare expenses. ASCs are well-suited for minimally invasive orthopedic implant procedures, such as arthroscopy, which are increasingly popular due to their quicker recovery times and reduced post-operative pain.
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance, accounting for the largest orthopedic implants market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
In the North American market, orthopedic implants have seen consistent growth, particularly in sectors like healthcare facilities, specialized orthopedic clinics, and home care. Consumer awareness around joint health and elective surgeries is generally high in North America, making it a promising market for orthopedic products addressing conditions such as osteoarthritis, fractures, and degenerative disc diseases. Moreover, the presence of robust regulatory bodies like the FDA (Food and Drug Administration) adds credibility to approved devices, thereby potentially driving market demand. Companies operating in this region would benefit from aligning their marketing strategies with local healthcare trends, consumer preferences, and regulatory guidelines. With an aging population and increasing incidence of lifestyle-related orthopedic issues, there is a rising demand for innovative, safe, and efficient orthopedic solutions. Tailoring product offerings to meet these specific needs allows businesses to position themselves competitively in this lucrative market.
In the global orthopedic implants market, key market players are actively engaged in various strategies and initiatives to maintain and enhance their positions. Market leaders invest heavily in research and development to introduce innovative orthopedic implant products. This includes developing implants with advanced materials, designs, and features to improve patient outcomes and surgeon satisfaction. Key players often expand their product portfolios through acquisitions, mergers, and partnerships. This allows them to offer a comprehensive range of orthopedic implants, catering to various segments such as joint replacements, spine implants, trauma implants, and dental implants. Companies are expanding their global presence by entering new markets and regions. This involves securing regulatory approvals, establishing distribution networks, and adapting products to meet specific regional needs. Collaborations with healthcare institutions, research organizations, and orthopedic surgeons help key players gain insights into market trends, patient needs, and emerging technologies. Such alliances can also lead to the development of customized solutions.
Arthrex Inc.
Auxein Medical
B. Braun Melsungen AG
CONMED Corporation
Globus Medical Inc.
Integra LifeSciences
Johnson & Johnson
Medtronic Plc
Narang Medical Limited
Orthopaedic Implant Company
Smith & Nephew plc
Stryker Corporation
Zimmer Biomet
In March 2023, Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, announced plans to unveil the latest enhancements to ZBEdge(TM) Dynamic Intelligence(TM) at the American Academy of Orthopaedic Surgeon's (AAOS) 2023 Annual Meeting in Las Vegas.
In February 2022, the Johnson & Johnson Medical Devices Companies announced that DePuy Synthes has acquired CrossRoads(R) Extremity Systems, a Tennessee-based foot and ankle company that provides a broad range of procedure-specific, sterile-packed implants and instrumentation systems cleared for lower extremity indications.
In February 2022, Stryker (NYSE: SYK) announced that it has completed the previously announced acquisition of Vocera Communications, Inc. (NYSE: VCRA), a leader in digital care coordination and communication.